<DOC>
	<DOCNO>NCT01184118</DOCNO>
	<brief_summary>This study conduct find use inhaled corticosteroid affect upper airway ( UAW ) collapsibility sleep apnea risk . An inhaled corticosteroid common asthma controller medication like Flovent . Sleep apnea sleep deprive breathing ( SDB ) someone stop breathe short period time sleep . For reason , people asthma sleep apnea upper airway ( UAW ) collapsibility ( weakness ) general population . There many possible reason one might relate use inhaled corticosteroid . The overall hypothesis study determine whether inhaled fluticasone propionate ( FP ) increase UAW collapsibility ass tongue ( genioglossus muscle ) dysfunction potential underlying mechanism .</brief_summary>
	<brief_title>DREAM : Does Inhaled Fluticasone REsult Obstructive Sleep Apnea Manifestations ?</brief_title>
	<detailed_description>To address hypothesis , specifically aim determine effect 16 week treatment inhale FP hydrofluoroalkane-propelled meter dose inhaler ( HFA-MDI ) , 880 mcg twice daily , : Specific Aim 1 : UAW collapsibility , measure Pcrit NREM sleep ; Specific Aim 2 : Severity obstructive SDB sleep quality , quality life relate sleep apnea assess validated questionnaire ( Sleep Apnea scale Sleep Disorders Questionnaire [ SA-SDQ ] , Epworth Sleepiness Scale [ ESS ] ) Pittsburgh Sleep Quality Index [ PSQI ] , Sleep Apnea Quality Life Index [ SAQLI ] ) ; Specific Aim 3 : Tongue strength fatigability ( assess use Iowa Oral Performance Instrument )</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>1. age 1865 ; 2. history consistent asthma 3. symptom consistent NAEPP26 asthma severity step ≥2 ( past 24 week , presence following : daytime symptom &gt; 2 days/week ; nighttime symptom 3−4x/month ; short act bronchodilator use ( prevention exercise induce asthma ) &gt; 2 days/week , require addition controller therapy , use NAEPP Asthma Step Categorization guideline 4 . FEV1≥65 % 5. confirmation asthma diagnosis bronchodilator reversibility ( ≥12 % improvement FEV1 baseline follow 2 puff β2 agonist ) provocative concentration methacholine need produce 20 % fall FEV1 ( PC20 ) ≤ 8 mg/ml . 1. use inhale corticosteroid &gt; 2 week time last 6 month , use last 6 week 2. need use nasal steroid prior 6 month ( regular use allow without washout need prior test visit ) 3. use medication list Table 1 . Inhaled long act βadrenergics permit entry continue study 4. respiratory infection prior 4 week asthma exacerbation prior 6 week enrollment 5. presence lung diseases 6. evidence significant medical ( angina , heart failure , stroke ) psychiatric illnesses 7. diagnose osteopenia ( treatment ) osteoporosis 8. establish diagnosis neuromuscular disease ( e.g . multiple sclerosis , syringomyelia , transverse myelitis , amyotrophic lateral sclerosis ( ALS ) , poliomyelitis , Lambert Eaton syndrome , GuillainBarre syndrome , myasthenia gravis , myotonic dystrophy , mononeuritis multiplex , set polymyositis/dermatomyositis severe cervical spine disease ) 9 . BMI great 35 kg/m2 10. currently treatment OSA 11. new diagnosis OSA OAI &gt; 10/hour desaturation &lt; 70 % dPSG ( V2 12. pregnancy desire get pregnant upcoming 6 month ( subject childbearing potential must agree use acceptable method birth control per ACRN guideline , state consent form : i.e . postmenopausal [ 1 year since last menses ] surgically sterile [ hysterectomy , tubal ligation , vasectomy monogamous partner ] , subject must use one follow acceptable birth control method : abstinence , birth control pill , diaphragm , intrauterine device [ IUD ] , Norplant , DepoProvera , NuvaRing , birth control patch [ e.g. , Ortho Evra ] , single double barrier method [ condom plus foam/jelly condom plus diaphragm ] ) 13. cigarette &gt; 1pack/month cigar year study overall tobacco use great 10 pack year 14. inability abstain alcohol ingestion 24 hour prior sleep study 15. current use benzodiazepins , opioids barbiturate ; 16 ) current use recreational drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>asthma</keyword>
	<keyword>sleep apnea</keyword>
</DOC>